Imodium Softgels (Loperamide Hydrochloride)

• Loperamide Hydrochloride is an opioid receptor agonist used to manage diarrheal conditions.
• Acute nonspecific diarrhea: decreases stool frequency and liquidity, offering rapid symptomatic relief in sudden‑onset diarrheal episodes.
• Chronic diarrhea: provides ongoing reduction of bowel movements and improves stool consistency for long‑term diarrheal disorders.
• Travel‑associated diarrhea: helps control symptoms during short trips, allowing better tolerance of oral intake and activities.
• Irritable bowel syndrome with diarrhea (IBS‑D): may reduce urgency and frequency of loose stools, supporting symptom management.
• Acute infectious diarrhea: adjunctive therapy to reduce stool output while underlying infection is treated.

• Loperamide Hydrochloride acts peripherally on the μ‑opioid receptors located in the myenteric plexus of the gastrointestinal tract. By activating these receptors, it inhibits acetylcholine release, reduces smooth‑muscle contractions, and slows intestinal transit. The prolonged transit time allows greater absorption of water and electrolytes, resulting in firmer stools and decreased frequency of bowel movements. Its action is confined to the gut because it does not cross the blood‑brain barrier in significant amounts.

Loperamide Hydrochloride may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Nausea: mild stomach upset or queasiness.
• Constipation: reduced bowel movements leading to hard stools.
• Abdominal cramps: intermittent discomfort in the abdomen.

Serious or Rare Side Effects

• Severe constipation: risk of bowel obstruction.
• Cardiac arrhythmias: especially with high doses or drug interactions.
• Allergic reactions: rash, itching, swelling, or anaphylaxis.

When using Imodium Softgels, several precautions should be observed to ensure safe and effective therapy.

• Age restriction: not recommended for children under 2 years without medical supervision.
• Dehydration risk: maintain adequate fluid intake while treating diarrhea.
• Underlying infection: avoid use if bacterial dysentery or colitis is suspected without physician advice.
• Medication history: disclose use of other opioids or CYP3A4 inhibitors.
• Pregnancy and lactation: consult a healthcare professional before use as safety data are limited.
• Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Loperamide Hydrochloride can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase loperamide plasma levels and risk of cardiac toxicity.
• P-glycoprotein inhibitors (e.g., quinidine, ritonavir): can raise systemic exposure, leading to serious adverse effects.
• Other opioid agonists: additive central opioid effects, though loperamide acts peripherally.

Moderate Interactions (Monitor Closely)

• Antidiarrheal agents (e.g., bismuth subsalicylate): may reduce overall effectiveness.
• Anticholinergic drugs: may enhance constipation.
• Antifungal azoles (e.g., itraconazole): moderate increase in loperamide levels.